Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline solution used as a stimulant laxative for bowel cleansing.
## Primary Indications
* Bowel preparation for diagnostic procedures (e.g., sigmoidoscopy, colonoscopy)
* Bowel preparation for surgery
* Relief of occasional constipation
## Adult Dosing
* **Bowel Preparation:** Typically 1 bottle (118 mL) administered rectally as a single dose. Some protocols may recommend a second dose, but this increases risk. The full dose is usually administered shortly before the procedure or surgery. Follow specific institutional guidelines.
* **Constipation:** 1 bottle (118 mL) administered rectally as a single dose. Do not use more than 1 bottle in 24 hours.
## Pediatric Dosing
* **Ages 2 to under 12 years:** 1/2 bottle (59 mL) administered rectally as a single dose.
* **Under 2 years:** Contraindicated due to increased risk of severe adverse events.
## Dose Adjustments
* No dose adjustments are typically required for hepatic or renal impairment, however, caution is advised.
## Contraindications
* Congenital or acquired megacolon
* Anuria
* Congestive heart failure
* Newly diagnosed or existing severe renal insufficiency
* Intestinal obstruction or perforation
* Children under 2 years of age
* Patients with ileus or significant reduction in bowel motility
* Patients with conditions that increase risk of electrolyte imbalance or fluid overload
## Adverse Effects
* **Common:** Abdominal cramping, nausea, vomiting, bloating, rectal irritation.
* **Serious:**
* **Hyperphosphatemia:** Can lead to hypocalcemia, tetany, and cardiac arrhythmias.
* **Hypocalcemia:** Can manifest as muscle cramps, paresthesias, carpopedal spasm.
* **Hypernatremia:** Can lead to seizures, confusion, lethargy.
* **Fluid Overload:** Can lead to pulmonary edema, particularly in patients with renal or cardiac compromise.
* **Renal Damage:** Acute kidney injury can occur, especially with repeated or excessive use or in susceptible individuals.
* **Electrolyte Imbalances:** Significant disturbances in sodium, phosphate, calcium, and potassium can occur.
## Key Drug Interactions
* **Diuretics:** Increased risk of dehydration and electrolyte imbalance.
* **ACE inhibitors and ARBs:** Increased risk of hyperkalemia.
* **Lithium:** Increased risk of lithium toxicity due to altered excretion.
* **Other laxatives:** Avoid concomitant use of other stimulant laxatives or saline-containing products.
## Monitoring
* Monitor for signs and symptoms of electrolyte imbalance (e.g., muscle cramps, paresthesias, confusion, seizures).
* Monitor renal function (serum creatinine) in patients with risk factors for renal impairment or those experiencing symptoms.
* Monitor fluid status.
## Clinical Pearls
* Sodium phosphate enemas should be used with extreme caution in elderly patients, patients with renal disease, cardiac disease, or those on diuretic therapy due to the risk of severe electrolyte disturbances and fluid overload.
* Ensure adequate hydration before and after administration.
* Do not administer if bowel movements have occurred within the last 24 hours unless specifically indicated for procedural prep.
* If cramping or abdominal pain occurs, reduce the rate of administration or temporarily discontinue.
* Educate patients on the potential for severe adverse events, particularly in at-risk populations.
---
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before administering medications.
